why choose us

First received: January 1, 2023

Clinical Trial: Adiponectin, ICAM-1, VCAM-1 Levels and Metabolic Syndrome in Obese Adolescents

Study Status: Completed

Recruit Status: Completed

Condition: Obesity
Abdominal Obesity
Metabolic Syndrome
Hypertension
Hypertriglyceridemia

Study Type: Observational [Patient Registry]


Official Title: Adiponectin, ICAM-1, VCAM-1 Levels and Metabolic Syndrome in Obese Adolescents

Brief Summary: Adipose tissue secreting a number of adipokines which regulate insulin sensitivity, energy metabolism and vascular homeostasis, so the dysfunction of adipose tissue is linked with the incidence of obesity accompanied with insulin resistance, hypertension and cardiovascular disease (1). Obesity is known to alters the expression of adipokines due to the adipose tissue hypertrophy (2), including adiponectin, in which able to exert a potent anti-inflammatory and vascular protective effect (2).It has been proposed that…

Read more